Teva Applies Pressure, Purchases Mylan Stock

May 27, 2015

Bloomberg Business

Bloomberg reported that Teva Pharmaceutical Industries Ltd. bought 1.35 percent of Mylan stock, putting pressure on the company to accept a takeover offer.

“Acquiring shares of Mylan underscores our commitment to consummating a transaction as soon as possible,” Teva said in a statement. Read the Bloomberg article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments